Tag: Cannabinoids

CMS Continues Beneficiary Engagement Incentive for Hemp-Derived Products amid Federal Concerns

Discover CMS's continued engagement with hemp-derived products for Medicare recipients amidst growing safety and regulatory concerns in the industry.